美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
58468-0132-2	58468-0132	HUMAN PRESCRIPTION DRUG	Renvela	SEVELAMER CARBONATE	POWDER, FOR SUSPENSION	ORAL	20090812	N/A	NDA	NDA022318	Genzyme Corporation	SEVELAMER CARBONATE	800 mg/1	90 PACKET in 1 CARTON (58468-0132-2) / 1 POWDER, FOR SUSPENSION in 1 PACKET (58468-0132-1)
0955-1054-90	0955-1054	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate	Sevelamer Carbonate	POWDER, FOR SUSPENSION	ORAL	20180101	N/A	NDA AUTHORIZED GENERIC	NDA022318	Winthrop U.S, a business of sanofi-aventis U.S. LLC	SEVELAMER CARBONATE	2.4 g/1	90 PACKET in 1 BOX (0955-1054-90) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0955-1054-01)
0955-1052-90	0955-1052	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate	Sevelamer Carbonate	POWDER, FOR SUSPENSION	ORAL	20180101	N/A	NDA AUTHORIZED GENERIC	NDA022318	Winthrop U.S, a business of sanofi-aventis U.S. LLC	SEVELAMER CARBONATE	.8 g/1	90 PACKET in 1 BOX (0955-1052-90) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0955-1052-01)
58468-0131-2	58468-0131	HUMAN PRESCRIPTION DRUG	Renvela	SEVELAMER CARBONATE	POWDER, FOR SUSPENSION	ORAL	20090812	N/A	NDA	NDA022318	Genzyme Corporation	SEVELAMER CARBONATE	2400 mg/1	90 PACKET in 1 CARTON (58468-0131-2) / 1 POWDER, FOR SUSPENSION in 1 PACKET (58468-0131-1)